Show items per page
Elements: 162
Page 1 on 4
 TitleAuthors / EditorsDate
add to browser selection
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudine Sudre, Philippe; Chave, J. P.; Ruef, Christian; Iten, A.; ... Hirschel, Bernard 1997
add to browser selection
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study Ledergerber, Bruno; Egger, M.; Erard, V.; Weber, R.; ... Telenti, A. 1999
add to browser selection
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study Furrer, Hansjakob; Egger, M.; Opravil, M.; Bernasconi, Enos; ... Malinverni, R. 1999
add to browser selection
Zweitinfektion mit HIV: Mythos oder Realitat? Vernazza, P. L.; Bernasconi, Enos; Hirschel, Bernard 2000
add to browser selection
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Vernazza, P. L.; Bucher, H. C.; Opravil, M.; ... Hirschel, Bernard 2000
add to browser selection
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study Fellay, Jacques; Boubaker, K.; Ledergerber, Bruno; Bernasconi, Enos; ... Telenti, A. 2001
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients Battegay, M.; Vernazza, P. L.; Bernasconi, Enos; Flepp, Markus; ... Hirschel, Bernard 2001
add to browser selection
Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000 Bernasconi, Enos; Jost, J.; Ledergerber, Bruno; Hirschel, Bernard; ... Sudre, Philippe 2001
add to browser selection
HIV transmission after suspension of highly active antiretroviral therapy Bernasconi, Enos; Vernazza, P. L.; Bernasconi, Alessandra; Hirschel, Bernard 2001
add to browser selection
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study Boubaker, K.; Flepp, Markus; Sudre, Philippe; Furrer, Hansjakob; ... Telenti, A. 2001
add to browser selection
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection Opravil, Milos; Hirschel, Bernard; Lazzarin, Adriano; Furrer, Hansjakob; ... Perrin, Luc 2002
add to browser selection
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) Opravil, Milos; Ledergerber, Bruno; Furrer, Hansjakob; Hirschel, Bernard; ... Weber, Rainer 2002
add to browser selection
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort Hirschel, Bernard; Flepp, Markus; Bucher, H. C.; Zellweger, Claudine; ... Ledergerber, Bruno 2002
add to browser selection
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy Greub, Gilbert; Cozzi-Lepri, Alessandro; Ledergerber, Bruno; Staszewski, Schlomo; ... Telenti, Amalio 2002
add to browser selection
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study Bernasconi, Enos; Boubaker, Karim; Junghans, Cornelia; Flepp, Markus; ... Telenti, Amalio 2002
add to browser selection
Epidemiology of methicillin-resistant Staphylococcus aureus: results of a nation-wide survey in Switzerland Blanc, Dominique; Pittet, Didier; Ruef, Christian; Widmer, A. F.; ... Francioli, Patrick 2002
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival Staehelin, Cornelia; Rickenbach, Martin; Low, Nicola; Egger, Martin; ... Furrer, Hansjakob 2003
add to browser selection
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study Wolf, Katja; Young, James; Rickenbach, Martin; Vernazza, Pietro; ... Bucher, H. C. 2003
add to browser selection
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population Jaggy, Christian; von Overbeck, Jan; Ledergerber, Bruno; Schwarz, Claude; ... Hirschel, Bernard 2003
add to browser selection
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study Kaufmann, G. R.; Perrin, Luc; Pantaleo, Guiseppe; Opravil, Milos; ... Battegay, Manuel 2003
add to browser selection
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART Fagard, Catherine; Le Braz, Michelle; Gunthard, Huldrych; Hirsch, H. H.; ... Hirschel, Bernard 2003
add to browser selection
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection Fagard, Catherine; Oxenius, Annette; Gunthard, Huldrych; Garcia, Felipe; ... Hirschel, Bernard 2003
add to browser selection
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial Ananworanich, Jintanat; Nuesch, Reto; Le Braz, Michelle; Chetchotisakd, Ploechan; ... Yerly Ferrillo, Sabine 2003
add to browser selection
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point Trkola, Alexandra; Kuster, Herbert; Leemann, Christine; Oxenius, Annette; ... Gunthard, Huldrych 2004
add to browser selection
Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study Hasse, Barbara; Ledergerber, Bruno; Egger, Mathias; Egger, Martin; ... Gunthard, Huldrych 2004
add to browser selection
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection Kaufmann, G. R.; Khanna, Nina; Weber, Rainer; Perrin, Luc; ... Battegay, Manuel 2004
add to browser selection
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control study Felley, Christian; Morris, Michael Andréw; Wonkam, Ambroise; Hirschel, Bernard; ... Frossard, Jean-Louis 2004
add to browser selection
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study Young, Jim; De Geest, Sabina; Spirig, Rebecca; Flepp, Markus; ... Bucher, H. C. 2004
add to browser selection
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss Schupbach, Jorg; Gunthard, Huldrych; Joos, Beda; Fischer, Marek; ... Hirschel, Bernard 2005
add to browser selection
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders Tarr, P. E.; Taffe, Patrick; Bleiber, Gabriela; Furrer, Hansjakob; ... Telenti, Amalio 2005
add to browser selection
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study Rauch, Andri; Rickenbach, Martin; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2005
add to browser selection
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy Kaufmann, G. R.; Furrer, Hansjakob; Ledergerber, Bruno; Perrin, Luc; ... Battegay, Manuel 2005
add to browser selection
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study Young, Jim; Rickenbach, Martin; Weber, Rainer; Furrer, Hansjakob; ... Bucher, H. C. 2005
add to browser selection
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study Young, Jim; Weber, Rainer; Rickenbach, Martin; Furrer, Hansjakob; ... Bucher, H. C. 2005
add to browser selection
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study Glass, T. R.; De Geest, Sabina; Weber, Rainer; Vernazza, P. L.; ... Bucher, H. C. 2006
add to browser selection
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study Glass, T. R.; Ungsedhapand, C.; Wolbers, M.; Weber, R.; ... Bucher, H. C. 2006
add to browser selection
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study Zinkernagel, A. S.; von Wyl, Viktor; Ledergerber, Bruno; Rickenbach, Martin; ... Weber, Rainer 2006
add to browser selection
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial Ananworanich, Jintanat; Gayet-Ageron, Angèle; Le Braz, Michelle; Prasithsirikul, Wisit; ... Hirschel, Bernard 2006
add to browser selection
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study Simcock, Mathew; Blasko, Monika; Karrer, Urs; Bertisch, Barbara; ... Koller, M. T. 2007
add to browser selection
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy Sterne, J. A.; May, M.; Bucher, H. C.; Ledergerber, Bruno; ... Egger, M. 2007
add to browser selection
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types von Wyl, Viktor; Yerly Ferrillo, Sabine; Boni, Jurg; Burgisser, Philippe; ... Gunthard, Huldrych 2007
add to browser selection
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy Wolbers, Marcel; Battegay, Manuel; Hirschel, Bernard; Furrer, Hansjakob; ... Bucher, H. C. 2007
add to browser selection
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; Hirschel, Bernard; ... Bucher, H. C. 2007
add to browser selection
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy Wunder, D. M.; Bersinger, N. A.; Fux, C. A.; Mueller, N. J.; ... Furrer, Hansjakob 2007
add to browser selection
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification Keiser, Olivia; Fellay, Jacques; Opravil, Milos; Hirsch, H. H.; ... Furrer, Hansjakob 2007
add to browser selection
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study Ledergerber, Bruno; Furrer, Hansjakob; Rickenbach, Martin; Lehmann, Roger; ... Weber, Rainer 2007
<< previous | 1 | 2 | 3 | 4 |